The Alzheimer's Disease Drug Development Pipeline: What's New & What's Coming w/ Dr. Jeff Cummings Published 2023-09-27 Download video MP4 360p Recommendations 1:01:24 Training your brain to adopt healthful habits with Judson Brewer, MD, PhD 59:20 What's Lecanemab and what's next? 59:39 Alzheimer’s Clinical Trials 2024: The Inside Story with Dr. Jeffrey Cummings 39:36 Drug Discovery and Development Using AI - Vishnu Vettrivel (Cloudcircle) 44:52 The race to find a treatment for dementia | Four Corners 1:00:47 11/3/2023 - Monoclonal Antibody Treatments for Alzheimer's: the Good, the Bad, and the Difficult 1:09:07 Tap into the power of neuroplasticity with Michael Merzenich, PhD 33:50 A Deep Dive Into the Investigational Alzheimer’s Drug Donanemab | LiveTalk | Being Patient 1:04:55 How Confidence Affects Your Health with Ian Robertson, PhD 23:02 IBD A to Z for Patients and Caregivers 1:06:43 John Cryan, Ph.D.: The Brain: An Owner's Guide 2016 | The Center for BrainHealth® 09:31 The Drug Development Process in Pharma 1:25:31 Lecanemab for Treatment of Early Alzheimer’s Disease: Overview & Clinician Perspectives 16:18 Importance of Genetic Testing and Updates on Clinical Trials for Inherited Retinal Diseases 09:48 My life with mitochondrial disease - Shelley Beverley 49:20 Rudy Tanzi, PhD, presents Ending Alzheimer’s Disease by Preserving Brain Health 04:39 drug pipelines in large pharma 1:10:21 The Winner Effect: How Power Affects Your Brain | Dr. Ian Robertson | The Center for BrainHealth® 1:00:00 Dr. Monica Parker - Memory Loss, Dementia and Alzheimer's: What You Need to Know Similar videos 55:57 Jeffrey Cummings discusses Drug Development & the Changing Alzheimer's Disease Therapeutic Landscape 05:10 Alzheimer’s Drug Development: What’s Possible on the Path to 2025? 11:02 Progress for Alzheimer's Presentation: Dr. Jeffrey Cummings 00:43 Alzheimer's drug development: What's in the pipeline? 02:21 Jeffrey Cummings, MD, ScD: Trends in Alzheimer Disease Clinical Pipeline 04:28 OBD Guest Speaker series Dr Jeff Cummings (short version) 02:07 Jeffrey Cummings, MD, ScD: Repurposed Agents Within Alzheimer Disease Pipeline 01:35 Jeffrey Cummings, MD, ScD: Where Aducanumab Stands in Alzheimer Clinical Pipeline 48:18 Dr. Jeffrey Cummings - Alzheimer's Clinical Trials: History & Lessons 01:59 Alzheimers drug development: What's in the pipeline 02:28 A Timeline of Drug Development for Alzheimer’s Disease 58:34 OBD Guest Speaker Jeff Cummings (long version) 1:18:34 Tomorrow’s Breakthroughs Today: Dr. Jeff Cummings 06:59 US drugmaker: Alzheimer's development can be slowed down | DW News 05:25 Jeffrey L Cummings – Monoclonal antibodies in the treatment of Alzheimer's disease 04:15 Jeffrey Cummings, MD, ScD: Greatest Unmet Needs in Alzheimer Disease More results